{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["23(12)"],"submitter":["Hagedoorn NN"],"pubmed_abstract":["<h4>Objectives</h4>We aimed to describe the variation of hemostasis proteins in children with bacterial infections due to different pathogens ( Neisseria meningitidis, Streptococcus pneumoniae, Staphylococcus aureus , and group A streptococcus [GAS]) and to study hemostasis proteins in relation to mortality.<h4>Design</h4>Preplanned analysis in prospective cohort study.<h4>Setting</h4>Hospitals in five European countries (Austria, The Netherlands, Spain, Switzerland, and the United Kingdom).<h4>Patients</h4>Admitted children (2012-2016) with community-acquired infections due to meningococci ( n = 83), pneumococci ( n = 64), S. aureus (n = 50), and GAS ( n = 44) with available serum samples collected less than 48 hours after admission.<h4>Interventions</h4>None.<h4>Measurements and main res"],"journal":["Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies"],"pagination":["e543-e554"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9708080"],"repository":["biostudies-literature"],"pubmed_title":["Hemostasis Proteins in Invasive Meningococcal and Nonmeningococcal Infections: A Prospective Multicenter Study."],"pmcid":["PMC9708080"],"pubmed_authors":["Hagedoorn NN","van der Flier M","Vermont C","Dik WA","Hazelzet J","van Rijswijk A","Anderson S","Kohlfuerst DS","Kuijpers T","Herberg J","Levin M","Carrol ED","Emonts M","European Union Childhood Life-threatening Infectious Disease (EUCLIDS) Consortium","Driessen G","Schlapbach LJ","Zenz W","Boeddha NP","Martinon-Torres F","Agapow P"],"additional_accession":[]},"is_claimable":false,"name":"Hemostasis Proteins in Invasive Meningococcal and Nonmeningococcal Infections: A Prospective Multicenter Study.","description":"<h4>Objectives</h4>We aimed to describe the variation of hemostasis proteins in children with bacterial infections due to different pathogens ( Neisseria meningitidis, Streptococcus pneumoniae, Staphylococcus aureus , and group A streptococcus [GAS]) and to study hemostasis proteins in relation to mortality.<h4>Design</h4>Preplanned analysis in prospective cohort study.<h4>Setting</h4>Hospitals in five European countries (Austria, The Netherlands, Spain, Switzerland, and the United Kingdom).<h4>Patients</h4>Admitted children (2012-2016) with community-acquired infections due to meningococci ( n = 83), pneumococci ( n = 64), S. aureus (n = 50), and GAS ( n = 44) with available serum samples collected less than 48 hours after admission.<h4>Interventions</h4>None.<h4>Measurements and main res","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Dec","modification":"2025-04-05T11:48:34.274Z","creation":"2025-04-05T11:48:34.274Z"},"accession":"S-EPMC9708080","cross_references":{"pubmed":["36044313"],"doi":["10.1097/PCC.0000000000003056"]}}